Globus Medical (GMED) Revenue (2011 - 2026)

Globus Medical has reported Revenue for 16 years, with the latest figure at $759.9 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 27.04% year-over-year to $759.9 million; the trailing twelve-month figure through Mar 2026 stood at $3.1 billion (up 23.49% YoY), and the FY2025 full-year result was $2.9 billion, up 16.65% from the prior year.
• Revenue for Q1 2026 stood at $759.9 million, down from $826.4 million in the prior quarter.
• The five-year high for Revenue was $826.4 million in Q4 2025, with the low at $230.5 million in Q1 2022.
• Historically, Revenue has averaged $518.2 million across 5 years, with a median of $606.7 million in 2024.
• Annual changes were most pronounced in 2023 — Revenue soared 124.6% — and 2025, when it declined 1.41%.
• Globus Medical's Revenue stood at $274.5 million in 2022, then surged by 124.6% to $616.5 million in 2023, then grew by 6.61% to $657.3 million in 2024, then gained by 25.73% to $826.4 million in 2025, then dropped by 8.05% to $759.9 million in 2026.
• The last three Revenue figures came in at $759.9 million (Q1 2026), $826.4 million (Q4 2025), and $769.0 million (Q3 2025), per Business Quant data.